I’m Dr. Peter Salgo, a professor of medicine and anesthesiology at Columbia University College of Physicians and Surgeons; and an associate director of Surgical Intensive Care at New York-Presbyterian Hospital. Heart failure is associated with almost one million hospitalizations annually. Preventing readmissions through evidenced-based medicine is a large part of managing this patient population. As a result, much of their care falls to community physicians. On behalf of MD Magazine, I am excited to introduce an upcoming Peer Exchange focusing on congestive heart failure management. The topics will include: disease state information, understanding the current clinical guidelines, and applying them to hospital discharge planning to ensure a smooth transition of care to the community setting. Current therapeutic options, including the clinical rationale for treatment decision making will also be discussed. The esteemed panel will provide the valuable perspectives of the cardiologist as well as the clinical pharmacist in managing this disease. This video series will become available early 2017. We hope you will find it useful and informative.

Coming Soon; Congestive Heart Failure Peer Exchange



I’m Dr. Peter Salgo, a professor of medicine and anesthesiology at Columbia University College of Physicians and Surgeons; and an associate director of Surgical Intensive Care at New York-Presbyterian Hospital. Heart failure is associated with almost one million hospitalizations annually. Preventing readmissions through evidenced-based medicine is a large part of managing this patient population. As a result, much of their care falls to community physicians. On behalf of MD Magazine, I am excited to introduce an upcoming Peer Exchange focusing on congestive heart failure management. The topics will include: disease state information, understanding the current clinical guidelines, and applying them to hospital discharge planning to ensure a smooth transition of care to the community setting. Current therapeutic options, including the clinical rationale for treatment decision making will also be discussed. The esteemed panel will provide the valuable perspectives of the cardiologist as well as the clinical pharmacist in managing this disease. This video series will become available early 2017. We hope you will find it useful and informative.
Episode 1 Coming Soon; Congestive Heart Failure Peer Exchange

Latest Peer Exchange

Fidaxomicin in the Treatment of Clostridium Difficile Infections
Fidaxomicin in the Treatment of Clostridium Difficile Infections
Factors That Impact Clostridium Difficile Infection Recurrence
Factors That Impact Clostridium Difficile Infection Recurrence
Monitoring for Treatment Response in Clostridium Difficile
Monitoring for Treatment Response in Clostridium Difficile
Metronidazole vs Vancomycin in Mild Clostridium Difficile
Metronidazole vs Vancomycin in Mild Clostridium Difficile
When to Suspect Diarrhea is Symptom of a Clostridium Difficile
When to Suspect Diarrhea is Symptom of a Clostridium Difficile
Community Sources of Clostridium Difficile
Community Sources of Clostridium Difficile
Letermovir Phase III Trial
Letermovir Phase III Trial
Risk Factors for Developing Clostridium Difficile Infections
Risk Factors for Developing Clostridium Difficile Infections
Letermovir for CMV Prophylaxis in Transplant Patients
Letermovir for CMV Prophylaxis in Transplant Patients
Understanding of the Dominant Strains of Clostridium Difficile
Understanding of the Dominant Strains of Clostridium Difficile
The Need for CMV Prophylaxis in the Transplant Setting
The Need for CMV Prophylaxis in the Transplant Setting
How Clostridium Difficile Affects the Gastrointestinal System
How Clostridium Difficile Affects the Gastrointestinal System
Morbidity from CMV Infection in Transplant Patients
Morbidity from CMV Infection in Transplant Patients
Why Clostridium Difficile Infections Occur in the Community
Why Clostridium Difficile Infections Occur in the Community
Monitoring Azole Levels in Transplant Patients
Monitoring Azole Levels in Transplant Patients

Most Popular

@MDMagazine

$vAR$